Biocatalysts Ltd launch Nuclease for the growing precision fermentation market
Nuclease 46L has been designed specifically as a cost-effective solution for the elimination of nucleic acids in a wide range of biotechnology applications.
Enzyme specialists, Biocatalysts Ltd, announce the launch of their new enzyme, Nuclease 46L (N046L) for the degradation of different types of nucleic acids from a broad range of sources. It has been designed specifically as a cost-effective solution for the elimination of DNA in a wide range of biotechnology applications.
Microbial (or precision-) fermentation technologies enable the economic production of specific products from enzymes to proteins at vast commercial scales. The scalability of microbial fermentation and the drive for commercialising sustainable manufacturing solutions has led to the requirement for further downstream processing including the need for the removal of nucleic acid residues.
As the food industry evolves, as does the advances and increased uptake in biotechnology solutions to meet growing market demands. Nuclease 46L is an efficient solution for the reduction of nucleic acids providing numerous benefits including increased efficiency during downstream processing and elimination of nucleic acids in the final food product. Furthermore, Nuclease 46L can be used in other applications outside of the food industry wherever nucleic acid reduction or elimination is desirable.
For further information on Biocatalysts Ltd.'s solutions for degradation of nucleic acids please read our product datasheet on Nuclease 46L or reach out to one of our enzyme experts.
